24 February, 2026
Let us turn back the clock to 24 March 2022. On that day, a striking piece of news made headlines around the world: microplastics had been found in human blood. What had once been considered a theoretical risk was now a measurable reality.
In 2026, we still lack answers to how much microplastic we carry in our bodies – and where it comes from.
SDU researchers Ayoub Laghrissi, Jacek Fiutowski and Aljaz Kramberger, in collaboration with consultant Ole Birger Vesterager Pedersen, professor at the Department of Clinical Immunology at Zealand University Hospital, and professor Vibeke Andersen from Odense University Hospital, aim to find those answers.
With funding from MedTech Odense, the team will develop a robotic platform that will make it possible to screen blood samples on a scale that has not previously been possible.
This is an excerpt from an article by a MedTech Odense partner.
Read the full article on the University of Southern Denmark’s website.
Facts
• MedTech Odense brings together research and technology with clinical needs and companies.
• It is a strategic and binding partnership between SDU, the Region of Southern Denmark, OUH and the region’s other hospitals, as well as the Municipality of Odense.
• In both 2025 and 2026, DKK 20 million has been earmarked to strengthen the medtech field by the owners, the Region of Southern Denmark and the University of Southern Denmark.
• The SERSbot project has received funding from MedTech Odense’s IDEA pool.